Real-world use of nirmatrelvir–ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study
Neil Krishan Aggarwal, Kyle C. Molina, Laurel Beaty, Tellen D. Bennett, Nichole E. Carlson, David Mayer, Jennifer L. Peers, Seth Russell, Matthew K. Wynia, Adit A. Ginde
Topics & Concepts
RitonavirMedicineRetrospective cohort studyAmbulatoryCoronavirus disease 2019 (COVID-19)CohortEmergency departmentCohort studyInternal medicineEmergency medicineVirologyHuman immunodeficiency virus (HIV)Viral loadPsychiatryAntiretroviral therapyDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19